Literature DB >> 21221862

Immune modulation in heart failure: past challenges and future hopes.

Jose H Flores-Arredondo1, Gerardo García-Rivas, Guillermo Torre-Amione.   

Abstract

Immune-modulation therapy has had great success in various inflammatory diseases. Despite the promising results of preliminary studies in anti-tumor necrosis factor-α therapies, large randomized studies have lacked positive clinical outcomes in patients with heart failure. These results have led to the idea that therapies directed toward specific inflammatory mediators may not be the answer and lead us toward the development of novel anti-inflammatory strategies that may involve a broader spectrum of inflammatory mediators. Therapeutic plasma exchange has been demonstrated as a safe treatment, and preliminary outcomes led us to develop new treatment schemes.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21221862     DOI： 10.1007/s11897-010-0044-2

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN： 1546-9530


  63 in total

Review 1.  Therapeutic apheresis in autoimmune and rheumatic diseases.

Authors:  A P Koo
Journal:  J Clin Apher       Date:  2000       Impact factor: 2.821

2.  Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Authors:  M A Munger; B Johnson; I J Amber; K S Callahan; E M Gilbert
Journal:  Am J Cardiol       Date:  1996-04-01       Impact factor: 2.778

3.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

4.  A peptide fragment of beta cardiac myosin heavy chain (beta-CMHC) can provoke autoimmune myocarditis as well as the corresponding alpha cardiac myosin heavy chain (alpha-CMHC) fragment.

Authors:  K Kohno; Y Takagaki; N Aoyama; H Yokoyama; H Takehana; T Izumi
Journal:  Autoimmunity       Date:  2001       Impact factor: 2.815

5.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

6.  Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy.

Authors:  D M McNamara; R Holubkov; R C Starling; G W Dec; E Loh; G Torre-Amione; A Gass; K Janosko; T Tokarczyk; P Kessler; D L Mann; A M Feldman
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

Review 7.  Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.

Authors:  Alida L P Caforio; Niall J Mahon; Francesco Tona; William J McKenna
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

8.  Nuclear Factor (NF) kappaB polymorphism is associated with heart function in patients with heart failure.

Authors:  Diogo G B Santos; Marina F Resende; José G Mill; Alfredo J Mansur; José E Krieger; Alexandre C Pereira
Journal:  BMC Med Genet       Date:  2010-06-09       Impact factor: 2.103

9.  Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.

Authors:  Alexander Staudt; Yvonne Staudt; Marcus Dörr; Marco Böhm; Fabian Knebel; Astrid Hummel; Lydia Wunderle; Malte Tiburcy; Klaus D Wernecke; Gert Baumann; Stephan B Felix
Journal:  J Am Coll Cardiol       Date:  2004-08-18       Impact factor: 24.094

10.  Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

Authors:  Douglas L Mann; John J V McMurray; Milton Packer; Karl Swedberg; Jeffrey S Borer; Wilson S Colucci; Jacques Djian; Helmut Drexler; Arthur Feldman; Lars Kober; Henry Krum; Peter Liu; Markku Nieminen; Luigi Tavazzi; Dirk Jan van Veldhuisen; Anders Waldenstrom; Marshelle Warren; Arne Westheim; Faiez Zannad; Thomas Fleming
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690
View more
  11 in total

1.  Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome.

Authors:  Christina Christersson; Tomasz Baron; Frank Flachskampf; Lars Lindhagen; Bertil Lindahl; Agneta Siegbahn
Journal:  J Cardiovasc Transl Res       Date:  2022-06-21       Impact factor: 4.132

Review 2.  Pathological ventricular remodeling: mechanisms: part 1 of 2.

Authors:  Jana S Burchfield; Min Xie; Joseph A Hill
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

Review 3.  Mechanisms and consequences of inflammatory signaling in the myocardium.

Authors:  Jihyun Ahn; Jaetaek Kim
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 4.  Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases.

Authors:  Erin G Rosenbaugh; Krupa K Savalia; Devika S Manickam; Matthew C Zimmerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-03       Impact factor: 3.619

Review 5.  The physiology of cardiovascular disease and innovative liposomal platforms for therapy.

Authors:  Guillermo U Ruiz-Esparza; Jose H Flores-Arredondo; Victor Segura-Ibarra; Guillermo Torre-Amione; Mauro Ferrari; Elvin Blanco; Rita E Serda
Journal:  Int J Nanomedicine       Date:  2013-02-09

6.  Identification of a Common Different Gene Expression Signature in Ischemic Cardiomyopathy.

Authors:  Yana Li; Qiu Jiang; Zhiwen Ding; Guijian Liu; Peng Yu; Guoliang Jiang; Ziqing Yu; Chunjie Yang; Juying Qian; Hong Jiang; Yunzeng Zou
Journal:  Genes (Basel)       Date:  2018-01-22       Impact factor: 4.096

7.  Phase II clinical trial testing the safety of a humanised monoclonal antibody anti-CD20 in patients with heart failure with reduced ejection fraction, ICFEr-RITU2: study protocol.

Authors:  Luis Sánchez-Trujillo; Carlos Jerjes-Sanchez; David Rodriguez; Jathniel Panneflek; Claudia Ortiz-Ledesma; Gerardo Garcia-Rivas; Guillermo Torre-Amione
Journal:  BMJ Open       Date:  2019-03-27       Impact factor: 2.692

8.  Evaluation of adenosine deaminase (ADA) isoenzymes activity and tumor necrosis factor-α (TNFα) concentration in chronic heart failure.

Authors:  IrajI Khodadadi; Mohammad Saleh Vahedi; Mohammad Abdi; Nasrin Daneshkhah; Rezgar Rahbari; Shahoo Menbari; Dara Ahmadi; Abbas Ahmadi; Fariba Lahoorpour; Mohammad Saied Hakhamaneshi; Saman Javid; Bahram Nikkhoo
Journal:  EXCLI J       Date:  2014-02-03       Impact factor: 4.068

Review 9.  The role of B cells in heart failure and implications for future immunomodulatory treatment strategies.

Authors:  Gerardo García-Rivas; Elena Cristina Castillo; Adrian M Gonzalez-Gil; José Luis Maravillas-Montero; Marion Brunck; Alejandro Torres-Quintanilla; Leticia Elizondo-Montemayor; Guillermo Torre-Amione
Journal:  ESC Heart Fail       Date:  2020-06-13

Review 10.  What Is the Role of the Inflammation in the Pathogenesis of Heart Failure?

Authors:  Elena C Castillo; Eduardo Vázquez-Garza; David Yee-Trejo; Gerardo García-Rivas; Guillermo Torre-Amione
Journal:  Curr Cardiol Rep       Date:  2020-09-10       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.